Data Presentation [PPT - 1.1 MB]
Upcoming SlideShare
Loading in...5
×
 

Data Presentation [PPT - 1.1 MB]

on

  • 873 views

 

Statistics

Views

Total Views
873
Views on SlideShare
873
Embed Views
0

Actions

Likes
0
Downloads
4
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • No objective that can be assessed is moving in the wrong direction.
  • High rate of visual impairment due to glaucoma in BNH reflects high rate of diabetes in this subpopulation.
  • High rate of visual impairment due to glaucoma in BNH reflects high rate of diabetes in this subpopulation.

Data Presentation [PPT - 1.1 MB] Data Presentation [PPT - 1.1 MB] Presentation Transcript

  • Healthy People 2010 Focus Area 4: Chronic Kidney Disease Progress Review September 21, 2006
  • 4-1. End-stage renal disease 4-2. Cardiovascular disease deaths in persons with chronic kidney failure 4-3. Counseling for chronic kidney failure care 4-4. Use of arteriovenous fistulas 4-5. Registration for kidney transplantation 4-6. Waiting time for kidney transplantation 4-7. End-stage renal disease due to diabetes 4-8a. Medical evaluation for persons with type 1 or type 2 diabetes and chronic kidney disease 4-8b. Medical treatment for persons with type 1 or type 2 diabetes and chronic kidney disease Status of Chronic Kidney Disease Objectives Improving Getting worse Baseline data only Target met
  • End-stage Renal Disease, By Race/Hispanic Origin Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Asian Incidence rate per 1,000,000 population 1999 2000 2001 2002 2003 2010 Target Total White Black Hispanic American Indian 1998 1997 2004 1,200 1,000 800 600 400 200 0
  • End-stage Renal Disease Due to Diabetes, By Race/Hispanic Origin Obj. 4-7 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Asian Incidence rate per 1,000,000 population 1999 2000 2001 2002 2003 2010 Target Total White Black Hispanic American Indian 1998 1997 2004 1,200 1,000 800 600 400 200 0
  • Asian 1999 2000 2001 2002 2003 Total White Black Hispanic American Indian 1998 1997 2004 1,200 1,000 800 600 400 0 ESRD and ESRD Due to Diabetes, By Race/Hispanic Origin Incidence rate per million 1999 2000 2001 2002 2003 1998 1997 2004 1,200 1,000 800 600 400 200 0 Asian 2010 Target Total Black Hispanic American Indian 200 White Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-7 End-stage Renal Disease End-stage Renal Disease Due to Diabetes 2010 Target
  • End-stage Renal Disease, By Race and Gender Incidence rate per 1,000,000 Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Men Women Asian American Indian Black White Asian American Indian Black White 1,200 1,000 800 600 400 200 0 1998-2000 2001-2003 2010 Target
  • End-stage Renal Disease, By Health Service Area, 1993 Incidence rate per 1,000,000 population Obj. 4-1 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.
  • End-stage Renal Disease, By Health Service Area, 2003 Incidence rate per 1,000,000 population Obj. 4-1 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.
  • Males End-stage Renal Disease Due to Diabetes, By Gender Incidence rate per 1,000,000 population 2010 Target Total Females Obj. 4-7 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. 1999 2000 2001 2002 2003 1998 1997 2004 200 180 160 140 120 100 80 60 40 20 0
  • Asian Use of Arteriovenous Fistulas* Among the Newly Diagnosed By Race/Hispanic Origin Percent 1999 2000 2001 2002 2003 2010 Target Total White Black Hispanic American Indian Obj. 4-4 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. The categories black and white exclude persons of Hispanic origin. Persons of Hispanic origin may be any race. SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performace Measures (CPM) project. 1998 50 60 40 30 20 10 0 70 80
  • Females Use of Arteriovenous Fistulas Among the Newly Diagnosed By Gender Percent 1999 2000 2001 2002 2003 2010 Target Total Males Obj. 4-4 SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performance Measures (CPM) project. 1998 50 60 40 30 20 10 0
  • Percent 2010 Target Obj. 4-8a 2000 2001 2002 2003 2004 Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Asian White Black Hispanic American Indian 50 60 40 30 20 10 0 Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease
  • Percent 2010 Target Obj. 4-8a 2000 2001 2002 2003 2004 Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Asian White Black Hispanic American Indian 50 60 40 30 20 10 0 Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease Medical evaluation include eye examinations, lipid testing, and glycosylated hemoglobin (HbA1c) testing
  • 0 Percent 2010 Target 40 20 Total Hispanic Asian Obj. 4-8b American Indian Black White Native Hawaiian Medical Treatment for Persons with Diabetes and Chronic Kidney Disease Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. * 30 10 * * * 2000
  • 0 Percent 2010 Target 40 20 Total Hispanic Asian Obj. 4-8b American Indian Black White Native Hawaiian Medical Treatment for Persons with Diabetes and Chronic Kidney Disease Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. * 30 10 * * * Medical treatment includes the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) 2000
  • Progress review data and slides are available on the web at: http://www.cdc.gov/nchs/hphome.htm